The present invention provides salts of Intedanib, crystalline forms of the salts of Intedanib, processes for their manufacture and their use in pharmaceutical compositions.
申请公布号
WO2012068441(A3)
申请公布日期
2012.08.16
申请号
WO2011US61352
申请日期
2011.11.18
申请人
RATIOPHARM GMBH;TEVA PHARMACEUTICALS USA, INC.;ALBRECHT, WOLFGANG;FISCHER, DIRK;JANSSEN, CHRISTIAN
发明人
ALBRECHT, WOLFGANG;FISCHER, DIRK;JANSSEN, CHRISTIAN